Maximize impact with visual aids
When using visual aids in presentations, it's important to remember to pace yourself.
When using visual aids in presentations, it's important to remember to pace yourself.
Don't speed through the visuals. People remember almost twice as much of what they see and hear as what they only hear. Photos, graphs, drawings, charts and bullet points projected on screen can help your presentation come to life and hold your audience's attention.
When a visual appears on screen, your audience feels physically compelled to look at it. Give them time! You may have seen these graphs and bullet points a hundred times but they're new to your audience. Help them along by reading the words, explaining the pie chart on the drawing and answering the questions that arise.
Pacing visual information is as important as pacing any other part of your presentation. To get your timing right, look first at the visual in silence. Then, reference the part of your visual you want your listeners to look at. Next, face the audience and look at one person. Then begin speaking to that person. Look back at the visual as often as you need to, but don't talk to the pie chart!
The benefit of this technique is that it forces you to pause. Pausing gives you time to look at the audience and check their reactions. Pausing gives you time to think. Pausing regulates your breathing and your rate of delivery. And purposeful pauses communicate confidence and authority.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
